In settling fraud case, New York Medicare Advantage insurer, CEO will pay up to $100M

A western New York health insurance provider for seniors and the CEO of its medical analytics arm have agreed to pay a total of up to $100 million to settle Justice Department allegations of fraudulent billing for health conditions that were exaggerated or didn’t exist.

APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company – Biotech Investments

EQS-News: APONTIS PHARMA AG / Key word(s): Personnel APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic

June 28, 2024

Extreme heat could lead to 233% increase in U.S. excess cardiovascular deaths, study says

When the human body is exposed to extreme heat, it tries to fight back. To keep us from cooking, our hearts pump faster and harder

October 30, 2023

In stunning outcome, Amylyx’s ALS drug fails large clinical trial

Amylyx Pharmaceuticals said Friday that its treatment for ALS, called Relyvrio, failed to provide any benefit for patients in a large clinical trial — a

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.